Tvardi Therapeutics TVRD Institutional Ownership

NASDAQ TVRD

$1.22 -0.03 (-2.40%)

As of: Oct 1, 2026 · 9:30 AM EDT

Institutions by Trading Activity

59 Institutions

Increased 22 37.3%

Unchanged 14 23.7%

Reduced 23 39.0%

Ownership Statistics

13F · as of 30 Jun, 2026

Institutional Ownership

23.75%

▼-5.07 pp QoQ

Shares Held by Institutions

2.23Mn

of 9.38Mn outstanding

▼-11.27% QoQ

Shares Outstanding

9.38Mn

7.15Mn held outside 13F filers

Institutional Investors

filed 13F for Jun 2026

▼-8 vs prior quarter

Net Shares Added (QoQ)

-283.00K

distributed since last quarter

Value of Holdings

$2.78Mn

reported market value

Shares Owned by Institutions

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Institutions

Accumulated Distributed

Latest quarter —

Net over range —

Accumulating quarters —

Ownership Summary

Quarter ending 30 Jun, 2026

Tvardi Therapeutics, Inc. (NASDAQ:TVRD) appears in 59 institutional 13F filings for the quarter ending June 2026.

These investors collectively held 23.7% of Tvardi Therapeutics's outstanding shares in June 2026, down from 28.8% in March 2026.
Their total shares held in TVRD decreased -11.27% quarter over quarter, and separately, investors owning Tvardi Therapeutics increased 22.92% from a year ago.
During the quarter, 22 of these 59 funds increased positions in TVRD, 23 reduced exposure, and 14 held steady.
In total, institutional investors held 2.23Mn shares in Tvardi Therapeutics as of June 2026, down by 283.0K shares quarter on quarter, and up 309.53K shares year over year.
Slate Path Capital LP holds the largest position in TVRD at 704.12K shares as of June 30, 2026, or 7.51% of shares outstanding.
Leading buyers of Tvardi Therapeutics shares for the quarter ending June 2026 were UBS Group AG (60.68K), SUSQUEHANNA INTERNATIONAL GROUP, LLP (33.16K), Russell Investments Group, Ltd. (19.92K), Savant Capital, LLC (19.46K), GSA CAPITAL PARTNERS LLP (17.89K).
Top sellers of TVRD stock for the quarter ending June 2026 included BlackRock, Inc. (292.6K), GEODE CAPITAL MANAGEMENT, LLC (91.99K), State Street Corp (63.33K), Northern Trust Corp (27.24K), AQR CAPITAL MANAGEMENT LLC (15.1K).
Per Business Quant data, the top 10 holders of Tvardi Therapeutics for the quarter ending June 2026 are Slate Path Capital LP (704.12K), VANGUARD CAPITAL MANAGEMENT LLC (344.38K), American Financial Group Inc (223.66K), UBS Group AG (111.13K), SILVERCREST ASSET MANAGEMENT GROUP LLC (101.03K), BlackRock, Inc. (95.48K), RENAISSANCE TECHNOLOGIES LLC (91.41K), GEODE CAPITAL MANAGEMENT, LLC (90.35K), Morgan Stanley (77.84K), Duncan Williams Asset Management, LLC (63.24K).

Form 13F Holdings

59 Institutional Holders

Report period 30 Jun, 2026

Total shares held 2.23Mn

Of outstanding 23.75%

#	Institution	CIK	Shares Held	% of Outstanding	Change (QoQ)	Change (%)	Value (USD)
1	Slate Path Capital LP	0001559706	704,118	7.51%	0	0.00%	$1.34Mn
2	VANGUARD CAPITAL MANAGEMENT LLC	0002100119	344,382	3.67%	▼326	-0.09%	$654.33K
3	American Financial Group Inc	0001042046	223,659	2.38%	0	0.00%	$424.95K
4	UBS Group AG	0001610520	111,133	1.18%	▲60,679	+120.27%	$211.15K
5	SILVERCREST ASSET MANAGEMENT GROUP LLC	0001232395	101,034	1.08%	0	0.00%	$191.97K
6	BlackRock, Inc.	0002012383	95,478	1.02%	▼292,597	-75.40%	$181.41K
7	RENAISSANCE TECHNOLOGIES LLC	0001037389	91,409	0.97%	▼691	-0.75%	$173.68K
8	GEODE CAPITAL MANAGEMENT, LLC	0001214717	90,350	0.96%	▼91,989	-50.45%	$171.74K
9	Morgan Stanley	0000895421	77,845	0.83%	▲4,951	+6.79%	$147.91K
10	Duncan Williams Asset Management, LLC	0002011771	63,241	0.67%	0	0.00%	$120.16K
11	VANGUARD FIDUCIARY TRUST CO	0000933478	44,710	0.48%	▼2,162	-4.61%	$84.95K
12	Russell Investments Group, Ltd.	0001692234	43,228	0.46%	▲19,921	+85.47%	$82.13K
13	State Street Corp	0000093751	33,900	0.36%	▼63,331	-65.13%	$64.41K
14	SUSQUEHANNA INTERNATIONAL GROUP, LLP	0001446194	33,165	0.35%	▲33,165	0.00%	$63.01K
15	AQR CAPITAL MANAGEMENT LLC	0001167557	27,096	0.29%	▼15,096	-35.78%	$51.48K
16	Northern Trust Corp	0000073124	21,836	0.23%	▼27,245	-55.51%	$41.49K
17	Savant Capital, LLC	0001482880	19,462	0.21%	▲19,462	0.00%	$49.43K
18	GSA CAPITAL PARTNERS LLP	0001362033	17,885	0.19%	▲17,885	0.00%	$34
19	DIADEMA PARTNERS LP	0002026172	16,607	0.18%	▲16,607	0.00%	$31.55K
20	XTX Topco Ltd	0001828301	14,868	0.16%	▲14,868	0.00%	$28.25K

Showing 1 to 20 of 59 holders